Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation.

par Siegel, P M, Muller, W J
Publié 1996

Multiple subelements within the polyomavirus enhancer function synergistically to activate DNA replication.

par Muller, W J, Dufort, D, Hassell, J A
Publié 1988

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

par Guy, C T, Cardiff, R D, Muller, W J
Publié 1992

Disposal of sewage and other wator-borne waster /

par Imhoff, Karl., Muller, W. J., Thistlethwayte, D. K.
Publié 1972.

Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.

par Webster, M A, Cardiff, R D, Muller, W J
Publié 1995

The polyomavirus enhancer comprises multiple functional elements.

par Mueller, C R, Muller, W J, Hassell, J A
Publié 1988

Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants.

par Muller, W J, Naujokas, M A, Hassell, J A
Publié 1984

Polyomavirus-plasmid recombinants capable of replicating have an enhanced transforming potential.

par Muller, W J, Naujokas, M A, Hassell, J A
Publié 1983

β1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression

par Huck, L., Pontier, S. M., Zuo, D. M., Muller, W. J.
Publié 2010

Polyomavirus origin for DNA replication comprises multiple genetic elements.

par Muller, W J, Mueller, C R, Mes, A M, Hassell, J A
Publié 1983

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.

par Siegel, P M, Dankort, D L, Hardy, W R, Muller, W J
Publié 1994

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.

par Siegel, P M, Ryan, E D, Cardiff, R D, Muller, W J
Publié 1999

Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling

par Bagci, H, Laurin, M, Huber, J, Muller, W J, Côté, J-F
Publié dans Cell Death Dis (2014)

Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.

par Dankort, D L, Wang, Z, Blackmore, V, Moran, M F, Muller, W J
Publié 1997

The int-2 gene product acts as an epithelial growth factor in transgenic mice.

par Muller, W J, Lee, F S, Dickson, C, Peters, G, Pattengale, P, Leder, P
Publié 1990

Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.

par Addison, C L, Braciak, T, Ralston, R, Muller, W J, Gauldie, J, Graham, F L
Publié 1995

neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.

par Li, B, Rosen, J M, McMenamin-Balano, J, Muller, W J, Perkins, A S
Publié 1997

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.

par Muthuswamy, S K, Siegel, P M, Dankort, D L, Webster, M A, Muller, W J
Publié 1994

Prevalence of viral antibodies and helminths in field populations of house mice (Mus domesticus) in southeastern Australia.

par Singleton, G. R., Smith, A. L., Shellam, G. R., Fitzgerald, N., Müller, W. J.
Publié 1993

Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.

par Jakubczak, J L, Merlino, G, French, J E, Muller, W J, Paul, B, Adhya, S, Garges, S
Publié 1996